HDAC Inhibitor Drug Screening Kit (Fluorometric)

Kits

貨號 Cat. No.
K340-100
規格 Size
K340-100
Sample Type
as well as many other biological fluids 、 Cell and tissue lysates 、 culture media 、 Plasma and Serum 、 urine

Description




Alternate Name :


 

Tag Line :


Non-radioactive, Two Easy Steps, HTS


 

Storage Conditions: -80°C


 

Shelf life: 12 months


 

Summary :


• Detection method- Fluorescence (Ex/Em 350-380/440-460 nm)
• Species reactivity- Mammalian
• Applications- Screening of compounds for HDAC inhibition by analyzing HDAC activity


 

Detection Method:


 

Features & Benefits:


• Simple two-step procedure
• Fast fluorescence-based method that eliminates radioactivity, extractions, or chromatography
• The assay is well suited for high throughput screening applications.


 

Description:


Inhibition of histone deacetylase (HDAC) has been implicated to modulate transcription and to induce apoptosis or differentiation in cancer cells. However, screening of compounds for HDAC inhibition has been difficult due to the lack of convenient tools for analyzing HDAC activity. The new HDAC Inhibitor Drug Screening Kit provides a fast, fluorescence-based method that eliminates radioactivity, extractions, or chromatography, as used in traditional assays. The new procedure requires only two easy steps, both performed on the same microtiter plate. First, your inhibitor candidates are mixed with HeLa Nuclear Extract and HDAC fluorometric substrate, which comprises an acetylated lysine side chain. Deacetylation of the substrate sensitizes the substrate, so that, in the second step, treatment with the Lysine Developer produces a fluorophore. The fluorophore can be easily analyzed using a fluorescence plate reader or a fluorometer. The assay is well suited for high throughput screening applications.


 





詢價 / 洽詢此產品 下載 PDF

回到產品列表

▲ LINE
諮詢